Bird and Bird LLP

United Kingdom

Bird and Bird LLP

United Kingdom
SEARCH FILTERS
Time filter
Source Type

Brazell L.,Bird and Bird LLP
IDrugs | Year: 2010

This feature article discusses the basic principles of patentability as related to vaccine research, and outlines recent cases in the US and EU in which vaccine patents have been considered. Issues regarding eligibility for supplementary protection, as currently being considered by the Court of Justice of the EU, are also outlined, as well as the implications of such issues in protecting future vaccine research. © Thomson Reuters (Scientific) Ltd.


Kamstra G.,Bird and Bird LLP
Journal of Commercial Biotechnology | Year: 2013

UK and European content is compiled and written by Bird & Bird LLP, an international law firm which advises Life Sciences clients on: • licensing intellectual property and know-how • R&D agreements and other commercial contracts • clinical trials • regulatory issues • risk management • private equity, venture capital, joint ventures, strategic alliances, mergers & acquisitions and stock exchange listings • patent & trade mark litigation • data protection • EU & competition law • product liability Bird & Bird has offices in Beijing, Bratislava, Brussels, Budapest, Düsseldorf, Frankfurt, The Hague, Helsinki, Hong Kong, London, Lyon, Madrid, Milan, Munich, Paris, Prague, Rome, Shanghai, Singapore, Stockholm and Warsaw and close ties with firms in other key centres in Europe, Asia and the United States. This section is intended to be a synopsis of recent legal developments and is not intended to be exhaustive. If any issue referred to in this section is to be relied on, specific advice should be sought.


Grist E.,Bird and Bird LLP
Journal of Commercial Biotechnology | Year: 2014

UK and European content is compiled and written by Bird & Bird LLP, an international law firm which advises Life Sciences clients on: • licensing intellectual property and know-how • R&D agreements and other commercial contracts • clinical trials • regulatory issues • risk management • private equity, venture capital, joint ventures, strategic alliances, mergers & acquisitions and stock exchange listings • patent & trade mark litigation • data protection • EU & competition law • product liability Bird & Bird has offices in Beijing, Bratislava, Brussels, Budapest, Düsseldorf, Frankfurt, The Hague, Helsinki, Hong Kong, London, Lyon, Madrid, Milan, Munich, Paris, Prague, Rome, Shanghai, Singapore, Stockholm and Warsaw and close ties with firms in other key centres in Europe, Asia and the United States. This section is intended to be a synopsis of recent legal developments and is not intended to be exhaustive. If any issue referred to in this section is to be relied on, specific advice should be sought.


Grist E.,Bird and Bird LLP
Journal of Commercial Biotechnology | Year: 2014

UK and European content is compiled and written by Bird & Bird LLP, an international law firm which advises Life Sciences clients on: • licensing intellectual property and know-how • R&D agreements and other commercial contracts • clinical trials • regulatory issues • risk management • private equity, venture capital, joint ventures, strategic alliances, mergers & acquisitions and stock exchange listings • patent & trade mark litigation • data protection • EU & competition law • product liability Bird & Bird has offices in Beijing, Bratislava, Brussels, Budapest, Düsseldorf, Frankfurt, The Hague, Helsinki, Hong Kong, London, Lyon, Madrid, Milan, Munich, Paris, Prague, Rome, Shanghai, Singapore, Stockholm and Warsaw and close ties with firms in other key centres in Europe, Asia and the United States. This section is intended to be a synopsis of recent legal developments and is not intended to be exhaustive. If any issue referred to in this section is to be relied on, specific advice should be sought.


The English High Court has considered the meaning of "making available to the public" by online transmission in the context of database rights and has determined that the act of making available is only committed in the country where the host server is located, and not the country where the material is accessed by the public. © 2011 Hogan Lovells. Published by Elsevier Ltd. All rights reserved.


Fetches R.,Bird and Bird LLP | Williams A.,Bird and Bird LLP
Food Science and Technology | Year: 2011

The life cycle of a brand in food industry if discussed by highlighting various issues to consider when creating, building, exploiting and enforcing a brand through trade marks. Trade mark protection is available through various routes at either the national level in the UK or at the Community level for all European Community countries. A trade mark must be capable of being graphically represented. This includes words, logos, slogans, the shape of goods or their packaging and also specific colors and sounds, such as advertising jingles. Once the trade mark application has passed the initial examination, it is published and third parties have a 2 or 3 month opportunity to oppose registration based on relative grounds. The validity of a trade mark can also be challenged post-registration if it becomes generic in the trade for the goods or services for which it is registered or if it is likely to mislead the public as to the nature, quality or geographical origin of the goods and services.


Charnley P.,Bird and Bird LLP
Computer Law and Security Review | Year: 2012

The European Court of Justice has ruled on the circumstances in which databases may be protected by the Database Directive. In a decision that renders the protection of databases a narrow concept, the ECJ appears to have introduced a new requirement that a database must comprise its author's "creative ability" in order to qualify for protection as a copyright work. © 2012 Baker and McKenzie LLP. Published by Elsevier Ltd. All rights reserved.

Loading Bird and Bird LLP collaborators
Loading Bird and Bird LLP collaborators